Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
34.24    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.44 (4.253%)
Market Cap: £547.50m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Board Changes

16 Jan 2025 07:00

RNS Number : 4829T
Hays PLC
16 January 2025
 

16 January 2025

 

HAYS PLC

BOARD CHANGES

Hays plc ("Hays") today announces the appointment of Michael Findlay to its Board as a Non-Executive Director and Chair-designate. He will join the Board on 20 January 2025 and will succeed Andrew Martin as Non-Executive Chair from 1 May 2025. Andrew will retire on 1 May 2025 after nearly 8 years on the Board.

Michael Findlay is currently Non-Executive Chair of London Stock Exchange plc and a Non-Executive Director of International Distribution Services plc and Jarrold & Sons Limited. Michael is also Chair of Morgan Sindall Group plc but announced yesterday that he will be stepping down from the Board on 28 July 2025. Previous roles include co-head of investment banking for UK and Ireland at Bank of America and Senior Independent Director at UK Mail Group plc.

Cheryl Millington, Hays' Senior Independent Director, who led the succession process, said: "I am delighted that Michael will be joining the Hays Board. Michael is a highly accomplished business leader and a proven Non-Executive and Chair. Having spent his executive career in corporate broking and investment banking, Michael has advised many leading UK plcs on a wide range of strategic, financing and governance matters. He also brings a strong understanding of people intensive and service orientated businesses."

"I also want to take this opportunity to thank Andy on behalf of the Board for his exemplary leadership, during a period of significant change for the Group, and wish him all the very best for the future."

Michael said: "I am delighted to be joining Hays and I look forward to working with the Board and the executive team to drive forward the Group's strategy to create significant value for all stakeholders."

Andy Martin commented: "It has been a privilege to serve on the Board of Hays for nearly 8 years. It is a great company and I wish all of the incredible team every success for the future, and wish Michael all the very best as he leads the Board on this next important step of the Hays journey."

This announcement is made in accordance with Listing Rule 6.4.6. There are no further matters to be disclosed under Listing Rule 6.4.8.

 

Enquiries

Hays plc

Rachel FordKean Marden

FGS GlobalGuy Lamming / Anjali Unnikrishnan / Richard Crowley

 

General Counsel & Company Secretary

Head of Investor Relations & ESG

 

+44 (0) 333 010 2682

+44 (0) 333 010 7092hays@fgsglobal.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVANRVAUAAAR
Date   Source Headline
4th Apr 20222:32 pmRNSDirector/PDMR Shareholding
1st Apr 202210:00 amRNSTotal Voting Rights
1st Apr 20229:30 amRNSSBTi approval for carbon reduction targets
31st Mar 20221:05 pmRNSDirector/PDMR Shareholding
17th Mar 20225:06 pmRNSTransaction in Own Shares
16th Mar 20225:06 pmRNSTransaction in Own Shares
15th Mar 20225:05 pmRNSTransaction in Own Shares
14th Mar 20225:20 pmRNSTransaction in Own Shares
11th Mar 20224:56 pmRNSTransaction in Own Shares
10th Mar 20225:00 pmRNSTransaction in Own Shares
9th Mar 20224:57 pmRNSTransaction in Own Shares
8th Mar 20225:02 pmRNSTransaction in Own Shares
7th Mar 20225:00 pmRNSTransaction in Own Shares
4th Mar 20224:59 pmRNSTransaction in Own Shares
3rd Mar 20225:06 pmRNSTransaction in Own Shares
2nd Mar 20225:02 pmRNSTransaction in Own Shares
1st Mar 20224:58 pmRNSTransaction in Own Shares
1st Mar 202210:00 amRNSTotal Voting Rights
28th Feb 20225:15 pmRNSTransaction in Own Shares
25th Feb 20225:22 pmRNSTransaction in Own Shares
24th Feb 20229:23 amRNSDirector/PDMR Shareholding
24th Feb 20227:02 amRNSDirectorate Change
24th Feb 20227:00 amRNSHalf-year Report
1st Feb 202210:15 amRNSBlock listing Interim Review
1st Feb 202210:00 amRNSTotal Voting Rights
1st Feb 20229:00 amRNSDirector Declaration
13th Jan 20227:00 amRNSSecond Quarter Trading Update
4th Jan 202211:54 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSTransaction in Own Shares
30th Dec 20215:19 pmRNSTransaction in Own Shares
30th Dec 20217:05 amRNSTransaction in Own Shares
29th Dec 20217:00 amRNSTransaction in Own Shares
23rd Dec 20214:55 pmRNSTransaction in Own Shares
23rd Dec 20217:05 amRNSTransaction in Own Shares
21st Dec 20216:25 pmRNSTransaction in Own Shares
21st Dec 20217:05 amRNSTransaction in Own Shares
17th Dec 20215:19 pmRNSTransaction in Own Shares
16th Dec 20215:13 pmRNSTransaction in Own Shares
15th Dec 20216:17 pmRNSTransaction in Own Shares
14th Dec 20216:07 pmRNSTransaction in Own Shares
14th Dec 202111:27 amRNSTreasury Share Purchase Programme
14th Dec 20217:49 amRNSHolding(s) in Company
1st Dec 202110:00 amRNSTotal Voting Rights
29th Nov 20214:59 pmRNSTransaction in Own Shares
26th Nov 20214:51 pmRNSTransaction in Own Shares
26th Nov 20213:13 pmRNSResult of AGM - Replacement
25th Nov 20215:02 pmRNSTransaction in Own Shares
24th Nov 20214:55 pmRNSTransaction in Own Shares
23rd Nov 20215:33 pmRNSTransaction in Own Shares
22nd Nov 20214:59 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.